SLS Sellas Life Sciences
- 1.430
- +0.010+0.70%
Sellas Life Sciences News
Sellas Life Sciences | D: Filing D
Sellas Life Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(6.5%)
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Stergiou Angelos M.
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director SCHEINBERG DAVID A
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer WOOD BARBARA A
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Burns John Thomas
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Varian John
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Francomano Robert
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Wasman Jane
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Kalin Katherine Bach
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer WOOD BARBARA A
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Stergiou Angelos M.
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Francomano Robert
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities-CFO Burns John Thomas
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities
Sellas Life Sciences | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
